Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Osinusi

Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV and HIV-1

Journal of Hepatology

English

Related publications

Ledipasvir and Sofosbuvir for HCV-infection in Patients Coinfected With HBV

Antiviral Therapy

Infectious Diseases

English

Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants During SOF/LDV Combination Therapy Against Genotype 1b Hepatitis C Virus (HCV)

Scientific Reports

Multidisciplinary

English

Effectiveness of 8- Or 12-Weeks of Ledipasvir and Sofosbuvir in Real-World Treatment-Naïve, Genotype 1 Hepatitis C Infected Patients

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health

Occupational Health

English

Efficacy of an 8-Week Course of Sofosbuvir and Ledipasvir for the Treatment of HCV Infection in Selected HIV-infected Patients

Molecular Biology

English

Randomised Clinical Trial: Sofosbuvir and Ledipasvir in Patients With Transfusion-Dependent Thalassaemia and HCV Genotype 1 or 4 Infection

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

English

All-Oral DAA Therapy Against HCV in HIV/HCV-coinfected Subjects in Real-World Practice: Madrid-CoRe Findings

English

Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders

BMC Infectious Diseases

Infectious Diseases

English